144 related articles for article (PubMed ID: 30684530)
21. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.
Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S
Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965
[TBL] [Abstract][Full Text] [Related]
22. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.
Goodman JE; Jensen LT; He P; Yager JD
Pharmacogenetics; 2002 Oct; 12(7):517-28. PubMed ID: 12360102
[TBL] [Abstract][Full Text] [Related]
23. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia.
Murphy BC; O'Reilly RL; Singh SM
Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):37-42. PubMed ID: 15635661
[TBL] [Abstract][Full Text] [Related]
24. Chronic coexposure to arsenic and estrogen potentiates genotoxic estrogen metabolic pathway and hypermethylation of DNA glycosylase MBD4 in human prostate epithelial cells.
Treas J; Roy P; Singh KP
Prostate; 2022 Sep; 82(13):1273-1283. PubMed ID: 35747940
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
[TBL] [Abstract][Full Text] [Related]
26. Gene expression of 17beta-estradiol-metabolizing isozymes: comparison of normal human mammary gland to normal human liver and to cultured human breast adenocarcinoma cells.
Lehmann L; Wagner J
Adv Exp Med Biol; 2008; 617():617-24. PubMed ID: 18497089
[TBL] [Abstract][Full Text] [Related]
27. Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study.
van der Knaap LJ; Schaefer JM; Franken IH; Verhulst FC; van Oort FV; Riese H
Genes Brain Behav; 2014 Sep; 13(7):618-25. PubMed ID: 24902721
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.
Ji Y; Olson J; Zhang J; Hildebrandt M; Wang L; Ingle J; Fredericksen Z; Sellers T; Miller W; Dixon JM; Brauch H; Eichelbaum M; Justenhoven C; Hamann U; Ko Y; Brüning T; Chang-Claude J; Wang-Gohrke S; Schaid D; Weinshilboum R
Cancer Res; 2008 Jul; 68(14):5997-6005. PubMed ID: 18632656
[TBL] [Abstract][Full Text] [Related]
29. Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia.
Polli A; Hendrix J; Ickmans K; Bakusic J; Ghosh M; Monteyne D; Velkeniers B; Bekaert B; Nijs J; Godderis L
J Transl Med; 2022 Oct; 20(1):487. PubMed ID: 36284330
[TBL] [Abstract][Full Text] [Related]
30. The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.
Lott SA; Burghardt PR; Burghardt KJ; Bly MJ; Grove TB; Ellingrod VL
Pharmacogenomics J; 2013 Jun; 13(3):264-71. PubMed ID: 22391769
[TBL] [Abstract][Full Text] [Related]
31. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
32. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.
Zahid M; Saeed M; Lu F; Gaikwad N; Rogan E; Cavalieri E
Free Radic Biol Med; 2007 Dec; 43(11):1534-40. PubMed ID: 17964424
[TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
35. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Activation of
Donovan MG; Selmin OI; Doetschman TC; Romagnolo DF
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652854
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
38. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
Manjegowda MC; Gupta PS; Limaye AM
Gene; 2017 May; 614():65-73. PubMed ID: 28286086
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells.
Rivenbark AG; Jones WD; Risher JD; Coleman WB
Epigenetics; 2006; 1(1):32-44. PubMed ID: 17998816
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
